IRMD
IRadimed CorporationNASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
54.72
PEG
3.24
P/B
12.96
P/S
14.68
EV/EBITDA
40.74
DCF Value
$38.00
FCF Yield
1.4%
Div Yield
1.3%
Margins & Returns
Gross Margin
76.7%
Operating Margin
31.2%
Net Margin
26.8%
ROE
23.8%
ROA
21.3%
ROIC
21.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $22.7M | $6.4M | $0.50 |
| FY 2025 | $83.8M | $22.5M | $1.75 |
| Q3 2025 | $21.2M | $5.6M | $0.43 |
| Q2 2025 | $20.4M | $5.8M | $0.45 |
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.12
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.